Baxter International BAX
NYSE BAX
$25.31 -0.34 (-1.35%)
As of: Oct 23, 2026 · 3:59 PM EDT

Baxter International (BAX) Gains from Sales and Divestitures (2016 - 2017)

Updated

Baxter International's Gains from Sales and Divestitures was -$54 million in FY2022.

Analysis

Baxter International (BAX) Gains from Sales and Divestitures (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Baxter International 13.09 Bn 5.22 Bn 1.03 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 2.00 Mn
Dec 31, 2016 2.00 Mn
Mar 31, 2016 17.00 Mn
API Access

Baxter International Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BAX&period=max&api_key=YOUR_API_KEY